Beijing, China

Liyan Yu

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liyan Yu. Retrieved from https://idiyas.com/inventor/liyan-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liyan Yu: Innovator in Antiviral Drug Development

Introduction

Liyan Yu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of antiviral drug development. His innovative work focuses on addressing the challenges of HIV drug resistance.

Latest Patents

Liyan Yu holds a patent for a "Group of amino substituted benzoyl derivatives and their preparation and their use." This invention involves a group of amino substituted benzoyl derivatives that have shown promise in antiviral applications. The research indicates that these 3-amino benzoyl derivatives not only exhibit combined activity for the hA3G/Vif target but also inhibit viral replication. This breakthrough could lead to the development of a novel clinical antiviral drug with higher efficiency.

Career Highlights

Liyan Yu is affiliated with the Chinese Academy of Medical Sciences, where he conducts his research. His work has been instrumental in advancing the understanding of antiviral compounds and their potential applications in treating viral infections.

Collaborations

Liyan Yu has collaborated with notable colleagues, including Jian-Dong Jiang and Shan Cen. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Liyan Yu's innovative contributions to antiviral drug development highlight his role as a key figure in the fight against HIV drug resistance. His work promises to pave the way for more effective treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…